University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Andrew D. Leavitt, MD

Andrew D. Leavitt, MD

Professor, Departments of Laboratory Medicine and Medicine (Div. of Hematology/Oncology), UCSF

Cancer Center Program Memberships

Affiliate Member


University of Michigan, Ann Arbor, B.S., 1979, Zoology
Harvard Medical School, M.D., 1984, Medicine

Professional Experience

  • 1982-1984
    Medical School Research Fellowship, Harvard Medical School, Department of Pediatric Hematology & Oncology (Laboratory of Dr. Robert Garcea; Project: Expression cloning, purification, and characterization of Polyoma major capsid protein, VP1)
  • 1984-1987
    Intern and Resident, Department of Internal Medicine, University of Michigan Hospitals
  • 1987-1988
    Chief Resident, Department of Internal Medicine, University of Michigan Hospitals
  • 1988-1991
    Hematology/Oncology Fellow, University of California, San Francisco
  • 1991-1992
    Molecular Medicine Fellow, University of California, San Francisco
  • 1989-1992
    Post-doctoral Research Fellow, University of California, San Francisco, Department of Microbiology & Immunology (Laboratory of Dr. Harold Varmus; Project: Biochemical characterization of retroviral integration)
  • 1992-2001
    Assistant Professor-in-residence, Department of Laboratory Medicine & Department of Medicine, UCSF
  • 1992-present
    Assistant Director, Blood Bank, Moffit-Long Hospitals, UCSF
  • 1994-present
    Medical Director, Adult Hematopoietic Progenitor Cell & Cellular Therapy Laboratory, Moffitt-Long Hospitals, UCSF
  • 2001-2007
    Associate Professor in Residence, Departments of Laboratory Medicine and Medicine (Div. of Hematology/Oncology), UCSF
  • 2007-present
    Professor in Residence, Departments of Laboratory Medicine and Medicine (Div. of Hematology/Oncology), UCSF

Honors & Awards

  • 1978-79
    James B. Angell Scholar, University of Michigan
  • 1979
    Phi Beta Kappa, University of Michigan
  • 1982-83
    Karin Grunebaum Cancer Research Foundation Fellowship, Harvard Medical School
  • 1984
    Cum Laude, Harvard Medical School
  • 1985
    Outstanding House Officer Award, Department of Internal Medicine, University of Michigan
  • 1991-92
    Burroughs Wellcome Research Fellowship
  • 1998
    Nomination for Small Group Teaching Award; UCSF Class of 2000
  • 2000
    Nomination for Small Group Teaching and Outstanding Lecture Award; UCSF Class of 2002
  • 2002
    Outstanding Lecture Award; UCSF Class of 2005
  • 2003
    Nominated for Kaiser Award for Excellence in Teaching
  • 2006
    Excellence in Teaching Award from the Haile T. Debas Academy of Medical Educator-UCSF

Selected Publications

  1. Vu K, Leavitt AD. Posttransfusion purpura with antibodies against human platelet antigen-4a following checkpoint inhibitor therapy: a case report and review of the literature. Transfusion. 2018 Sep 17.
    View on PubMed
  2. Leavitt AD. A Small Step Closer But Not Yet There: Oral Anti-Xa Agents and the Treatment of Cancer-Associated Venous Thromboembolism. J Natl Compr Canc Netw. 2018 May; 16(5):572-574.
    View on PubMed
  3. Lee EJ, Dykas DJ, Leavitt AD, Camire RM, Ebberink E, García de Frutos P, Gnanasambandan K, Gu SX, Huntington JA, Lentz SR, Mertens K, Parish CR, Rezaie AR, Sayeski PP, Cromwell C, Bar N, Halene S, Neparidze N, Parker TL, Burns AJ, Dumont A, Yao X, Chaar CIO, Connors JM, Bale AE, Lee AI. Whole-exome sequencing in evaluation of patients with venous thromboembolism. Blood Adv. 2017 Jul 11; 1(16):1224-1237.
    View on PubMed
  4. Lefrançais E, Ortiz-Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, Krummel MF, Leavitt AD, Passegué E, Looney MR. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017 04 06; 544(7648):105-109.
    View on PubMed
  5. Sakurai K, Zhao S, Takatoh J, Rodriguez E, Lu J, Leavitt AD, Fu M, Han BX, Wang F. Capturing and Manipulating Activated Neuronal Ensembles with CANE Delineates a Hypothalamic Social-Fear Circuit. Neuron. 2016 Nov 23; 92(4):739-753.
    View on PubMed
  6. Buckner TW, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost. 2016 07 04; 116(1):42-9.
    View on PubMed
  7. Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, Stuart JM, Göttgens B, Passegué E. Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. Cell Stem Cell. 2015 Jul 02; 17(1):35-46.
    View on PubMed
  8. Low E, Tessler R, Hauer KE, Leavitt AD, Miller B, Maa J. The Surgical Clerkship and Medical Student Performance in a Standardized Patient Case of Acute Cholecystitis. J Surg Educ. 2015 Sep-Oct; 72(5):1045-51.
    View on PubMed
  9. Roubinian NH, Leavitt AD. Shedding a little light on posttransfusion purpura. Transfusion. 2015 Feb; 55(2):232-4.
    View on PubMed
  10. Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015 Jan; 3(1):24-32.
    View on PubMed
  11. Liu KD, Wilson JG, Zhuo H, Caballero L, McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, Gotts JE, Rogers AJ, Levitt JE, Wiener-Kronish JP, Delucchi KL, Leavitt AD, McKenna DH, Thompson BT, Matthay MA. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care. 2014; 4:22.
    View on PubMed
  12. Kamata T, Dankort D, Kang J, Giblett S, Pritchard CA, McMahon M, Leavitt AD. Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720. Mol Cancer Res. 2013 Dec; 11(12):1530-41.
    View on PubMed
  13. Jacquot C, Moayeri M, Kim B, Shugarts S, Lynch KL, Leavitt AD. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion. 2013 Nov; 53(11):2715-21.
    View on PubMed
  14. Choi YS, Patena W, Leavitt AD, McManus MT. Widespread RNA 3'-end oligouridylation in mammals. RNA. 2012 Mar; 18(3):394-401.
    View on PubMed
  15. Leavitt AD, Hamlett I. Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease. Clin Transl Sci. 2011 Aug; 4(4):298-305.
    View on PubMed
  16. Leavitt AD. A vote for scientists as politicians. Science. 2011 Feb 25; 331(6020):1010.
    View on PubMed
  17. Leavitt AD. Are there more tricks in the bag for treating thrombocytopenia? J Clin Invest. 2010 Nov; 120(11):3807-10.
    View on PubMed
  18. King FW, Ritner C, Liszewski W, Kwan HC, Pedersen A, Leavitt AD, Bernstein HS. Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev. 2009 Dec; 18(10):1441-50.
    View on PubMed
  19. Alian A, Griner SL, Chiang V, Tsiang M, Jones G, Birkus G, Geleziunas R, Leavitt AD, Stroud RM. Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs. Proc Natl Acad Sci U S A. 2009 May 19; 106(20):8192-7.
    View on PubMed
  20. Nicholas CR, Gaur M, Wang S, Pera RA, Leavitt AD. A method for single-cell sorting and expansion of genetically modified human embryonic stem cells. Stem Cells Dev. 2007 Feb; 16(1):109-17.
    View on PubMed

Go to UCSF Profiles, powered by CTSI